DucommunDCO
DCO logo
Fair Value
US$181
Share price23 Jul
US$191.866.0% overvalued intrinsic discount
Loading
1Y110.44%
7D7.99%

Defense Modernization And Aerospace Recovery Will Reshape Markets

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
16 Sep 24
Updated
23 Jul 26
Views
193
Not Invested

Last Update 23 Jul 26

Fair value Increased 4.14%

DCO: Missile Demand And Aero Recovery Will Offset Defense Budget Concerns

Analysts have lifted their fair value estimate for Ducommun stock from $173.80 to $181.00, reflecting updated views that incorporate recent price target increases across the Street, along with expectations for continued benefits from commercial aerospace strength and missile and munitions demand, tempered by potential budget pressure on parts of the legacy defense portfolio.

Analyst Commentary

Recent research on Ducommun points to a split view, with bullish analysts highlighting earnings execution and exposure to commercial aerospace and missiles, while more cautious analysts focus on valuation and defense budget risk. Together, these views help frame how the stock’s risk and reward profile is being assessed across the Street.

Bullish Takeaways

  • Bullish analysts see Ducommun as well positioned to benefit from missiles and munitions demand, which they factor into higher price targets and updated estimates.
  • Several firms raised price targets into a US$150 to US$216 range after Q1 results, tying the changes to stronger than expected commercial aerospace performance and updated sector models.
  • The Q1 report, which included US$35.4 million of adjusted EBITDA that was above consensus, reinforced confidence in Ducommun’s execution and supported higher valuation frameworks.
  • Upcoming events such as an investor day and potential M&A are viewed by bullish analysts as possible positive catalysts that could support growth expectations and justify higher target prices.

Bearish Takeaways

  • Bearish analysts argue that near term upside is already reflected in Ducommun’s current valuation. In their view this limits the risk reward skew despite solid fundamentals.
  • There is concern that consensus forecasts may already capture much of the benefit from the missiles and munitions ramp, leaving less room for additional positive surprises on growth.
  • Some analysts highlight potential budget pressure on Ducommun’s legacy defense portfolio, which could offset strength in other segments and create execution risk.
  • While still acknowledging positive catalysts, bearish analysts frame them as largely anticipated. They see this as constraining further rerating without new incremental drivers.

What’s in the News for Ducommun

  • Ducommun is scheduled to host an analyst and investor day to provide an update on its VISION 2027 progress and to present a new five year roadmap, VISION 2032, aimed at outlining the next phase of the company’s plan.
  • The company reported during its Q1 2026 earnings call that it is actively pursuing acquisition opportunities, highlighting that it has reviewed multiple targets over the past 18 months while keeping a focus on valuation discipline.
  • Management indicated that Ducommun has a new US$650 million credit facility, which the company describes as lowering its cost of capital and increasing available capacity to pursue its acquisition plans.
  • Ducommun stated that it remains interested in transactions it believes can create value for shareholders and that it is aiming to potentially complete one or more acquisitions over the coming months, subject to valuation and fit.
  • Index provider Russell added Ducommun to several growth oriented benchmarks, including the Russell Small Cap Comp Growth, Russell 3000E Growth, Russell 2500 Growth, Russell 2000 Growth, Russell 2000 Growth Defensive, Russell 3000 Growth, and Russell 2000 Dynamic indices, while removing it from the Russell 3000E Index, Russell 3000E Value Benchmark, Russell Microcap Index, and Russell Microcap Value Benchmark Index.

Valuation Changes for Ducommun

  • Fair Value: Raised from $173.80 to $181.00, a modest increase of about 4.1% in the updated assessment.
  • Discount Rate: Adjusted slightly lower from 8.10% to about 8.06%, reflecting a small change in the required return used in the model.
  • Revenue Growth: Updated from roughly 8.13% to about 8.23%, indicating a small upward adjustment to Ducommun’s projected top line growth rate.
  • Profit Margin: Tweaked from about 12.63% to roughly 12.64%, a minimal change in expected profitability levels.
  • Future P/E: Moved from about 24.5x to roughly 25.4x, pointing to a slightly higher valuation multiple applied to Ducommun’s earnings outlook.
3 viewsusers have viewed this narrative update

Key Takeaways

  • Expansion in defense and commercial aerospace, driven by rising demand and modernization, positions Ducommun for sustained top-line growth and increased order activity.
  • Strategic focus on higher-margin products, automation, and domestic sourcing is improving margins, cash flow stability, and overall earnings quality.
  • Heavy dependence on volatile aerospace and defense markets, operational execution challenges, and uncertainty in acquisitions threaten Ducommun's revenue growth, margin stability, and diversification efforts.

Catalysts

About Ducommun
    Provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States.
What are the underlying business or industry changes driving this perspective?
  • Elevated global defense spending and the replenishment of missile and radar inventories-highlighted by strong double-digit growth in both segments and a 30% increase in missile backlog-positions Ducommun to sustain and expand revenue as defense modernization accelerates over the next several years, with increasing program content and order activity.
  • Strengthening demand for commercial aircraft, particularly with increasing Boeing 737 and 787 build rates and projected end to destocking in 2025/2026, underpins a likely recovery and longer-term rebound in top-line growth for Ducommun's commercial aerospace business.
  • Ongoing mix shift toward higher-margin engineered products and aftermarket (maintained at 23% of revenues, moving toward 25%+), together with value-driven pricing and restructuring actions, is increasing gross margins (recorded at 26.6% in Q2), which supports sustained improvements in net margins and earnings.
  • Facility consolidations, automation, and digital initiatives expected to generate $11-13 million in annual savings (with full benefits ramping in late 2025–2026), set the stage for further operating margin expansion and better cash flow conversion (targeting 100% in the coming years).
  • Minimal exposure to tariff impacts, and high percentage of domestic production and sourcing, should allow Ducommun to capitalize on the industry-wide shift toward supply chain localization, potentially capturing increased market share and stabilizing contract flows, thereby reducing earnings volatility and supporting stable free cash flow.
Ducommun Earnings and Revenue Growth

Ducommun Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Ducommun's revenue will grow by 8.2% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -3.4% today to 12.6% in 3 years time.
  • Analysts expect earnings to reach $134.8 million (and earnings per share of $5.54) by about July 2029, up from -$28.8 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 26.4x on those 2029 earnings, up from -91.3x today. This future PE is lower than the current PE for the US Aerospace & Defense industry at 38.1x.
  • Analysts expect the number of shares outstanding to grow by 1.08% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.06%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Ducommun continues to face significant cyclical risk connected to commercial aerospace customers like Boeing and Spirit AeroSystems; persistent destocking and uncertain ramp-up timelines introduce volatility in aerospace revenue, which could negatively impact top-line growth in low-demand cycles.
  • There is a growing concentration of revenue from the defense sector, especially missile and radar programs, exposing the company to shifts in U.S. government defense budgets and platform priorities-potentially impacting both revenue and margin stability if defense spending slows or focus shifts away from Ducommun's key franchises.
  • Execution risks associated with facility consolidation, product line recertification, and transitioning work to new or lower-cost locations (such as the ramp-up at Coxsackie and Guaymas) may lead to unforeseen production delays, temporary operating inefficiencies, or customer disruptions, adversely affecting near
  • and mid-term margins and earnings.
  • Ducommun's ability to scale up its higher-margin engineered product and aftermarket portfolio partly hinges on successful and timely acquisitions; intensifying competition for quality assets or delayed/integrated acquisitions could slow margin expansion and inhibit revenue diversification, limiting the pace of long-term earnings growth.
  • Sustained pressure from unfavorable sales mix (as seen in lower Structural Systems margins) and ongoing restructuring costs, combined with reliance on favorable product mix for margin gains, may challenge the company's ability to consistently expand net margins and achieve targeted profitability if market or execution tailwinds weaken.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $181.0 for Ducommun based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $216.0, and the most bearish reporting a price target of just $150.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.1 billion, earnings will come to $134.8 million, and it would be trading on a PE ratio of 26.4x, assuming you use a discount rate of 8.1%.
  • Given the current share price of $174.59, the analyst price target of $181.0 is 3.5% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Ducommun?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$181
vs US$191.866.0% overvalued intrinsic discount
PastFuture-57m1b2015201820212024202620272029Revenue US$1.1bEarnings US$134.8m
8.2%
Revenue growth
12.6%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Ducommun

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Excellent balance sheet and fair value.

Market capUS$2.8b
PB4.3x
Estimated Growth8.1%
Dividend YieldN/A
Full analysis

CEO & management

Stephen Oswald
CEO
8.9yrs
CEO Tenure

Provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States.